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The Olympics and Paralympic games bring joy to 
millions of people worldwide. This year it was held in 
Rio de Janeiro, Brazil amidst the Zika virus epidemic.  
On 1 February 2016, six months leading to the 
Olympics, the excitement was dampened by the World 
Health Organization declaration of the unprecedented 
vector-borne Zika virus (ZIKV) infection as a public 
health emergency of international concern [1]. At that 
point in time, people in Malaysia also felt the heat but 
had the consolation that the epidemic occurred across 
the Atlantic on the other side of the world. On 27 
August 2016, Singapore reported the first local 
confirmed case of ZIKV infection in the city-state [2]. 
It was only a matter of time that Malaysia reported its 
first confirmed case of ZIKV infection on 2 September 
2016 [3]. A 58-year old woman from Klang, Selangor 
was diagnosed as the first ZIKV case, who had earlier 
visited her daughter in Singapore who was infected by 
the ZIKV. As of 22 September 2016, the number of 
confirmed ZIKV cases in Malaysia has mounted to six 
with both Polynesia and Micronesia strains [4]. The 
occurrence of the disease in our continent brings to light 
how rapidly globalization and free movement of 
population across geographical borders can accelerate 
the arbovirus threat across the globe. 
  The ZIKV is spread through the bite of 
infected female Aedes mosquitoes and evidence has 
shown it can also spread via sexual and blood 
transmission [5]. Most of the cases are asymptomatic or 
subclinical while the symptomatic cases are self-
limiting. Other manifestations include neurological 
(Guillain-Barré syndrome and meningoencephalitis) 
and autoimmune (thrombocytopenic purpura and 
leukopenia) complications. More alarming is the 
association of the virus with infants born with 
microcephaly as a result of pregnant mothers infected 
with ZIKV with the risk of microcephaly ranges 
between 1-13% [6, 7], though the direct causal 
relationship is still under investigation.   
  In line with the international response, 
Malaysia has intensified the surveillance and 
management activities to control its ZIKV epidemic. 
These include clinical surveillance, laboratory 
surveillance, microcephaly and Guillain-Barre 
Syndrome case detection as well as preparedness and 
response at all ports of entry [8]. The public health 
delivery system in Malaysia has improved 
tremendously over the years following lessons learned 
from the emerging and re-emerging infectious diseases 
that affected the country over the recent years. Apart 
from those commendable measures; in light of this 
ZIKV outbreak, there are looming questions even 
though may appear elementary are nevertheless 
pertinent which the healthcare fraternity should address.  
Where do we go from here? What more do we need to 
know and do to help us manage and control this 
outbreak more efficiently and effectively? These 
questions would certainly pose a challenge to our public 
health especially when this arbovirus shares the same 
transmission vector with dengue and chikungunya i.e., 
Aedes mosquito where the authorities in Malaysia are 
still struggling to achieve a satisfactory control level in 
the country. 
  What shall we do?  We need a paradigm shift. 
We need to look at the re-emergence of ZIKV in a 
bigger perspective and manage it accordingly. Thus, 
instead of reacting merely to the notified ZIKV cases, 
we need to start strategizing how the transmission 
dynamics of the arbovirus family can be altered; this 
possibly means to look out of the box for the solutions. 
The conventional measures for prevention and control 
should also be complemented with two other elements 
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which are often neglected and underestimated in most 
outbreak response i.e., effective communication and 
social mobilization [9]. We must actively engage in 
communication with the public to hasten the 
containment by using all available forms of social 
medium. With tons of information about the virus in the 
media, the message should emphasize more on health 
education; empowering community on the case reports, 
transmission routes and infection complications rather 
than general statements on impact and world reaction 
towards ZIKV [10]. Only then social mobilization, 
which is commonly underutilized, may help mitigate 
the social and economic impact during an outbreak. An 
informed public understands the limitation and the need 
for the community. Only then we will appreciate the 
ripple effects - they will bring the community on board, 
educate the community to actively participate in the 
outbreak management, and share the responsibility as 
well as the outcome. Even when the community is 
faced with great anxiety, an informed public would be 
able to understand and support any move or decision 
made by the authorities concerned. 
  Of late, the controversy which surrounded 
ZIKV in Malaysia involved the ethical issue in dealing 
with termination of pregnancy in women with possible 
ZIKV-related fetal brain abnormalities. This was 
following a statement made by the Mufti of the Federal 
Territory, saying that Muslim women could abort their 
pregnancies if they were infected by the Zika virus to 
avoid the adverse effect on the lives of their families or 
the baby itself [11]. In Malaysia, the current law does 
not provide for abortion for pregnant mothers infected 
with Zika unless the pregnancy poses a threat to the 
mother’s life [12]. The recent Centres for Disease 
Control guideline does not include pregnancy 
termination as an option in managing suspected or 
confirmed Zika infection. It advocates monitoring the 
pregnancy with serial fetal ultrasounds in suspected or 
inconclusive cases and retest for ZIKV when ultrasound 
suggests abnormalities consistent with Zika infection 
and fall short in mentioning the alternative path of 
termination of pregnancy [13]. On the other hand, 
World Health Organization guideline mentions subtly 
on the discontinuation of pregnancy as a possible next 
step in the management of pregnancies with the 
likelihood of foetal brain abnormalities and states that 
women who wish to discontinue their pregnancy should 
receive accurate information about their options to the 
full extent of the law [14].  The failure to include 
guidelines on the option of safe, legal termination of 
pregnancy in Zika-response strategies is not only an 
issue of reproductive rights but also an issue of 
reproductive justice [15]. At the time of writing, it is 
learned that the Ministry of Health of Malaysia will 
hold a discussion on the matter with the National Fatwa 
Council regarding termination of pregnancy for women 
infected by the Zika virus in order to reach a consensus. 
Irrespective of the outcome of the fatwa, we are in the 
opinion that whether a woman who wishes to carry her 
pregnancy to term or discontinue the pregnancy should 
be offered appropriate counselling so that she, together 
with her partner, will be able to make a fully informed 
choice on the next step of action. 
  Despite being a re-emerging disease, there is 
still much evidence required to effectively manage and 
control the ZIKV outbreak. The disease behaviour 
remains dynamic, and a concerted effort by the health 
authorities and policy makers in implementing the 
appropriate dynamic alignment to meet the challenges 
is imperative. It also requires heightened public 
awareness of personal responsibility which is of 
paramount importance. The public health preventive 
strategies remain the cornerstone in the control of this 
mosquito-borne disease. 
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INTRODUCTION 
The Lancet published this early report by Andrew 
Wakefield et al on February 28th, 1998; “12 children 
(mean age 6 years [range 3–10], 11 boys) were 
referred to a paediatric gastroenterology unit with 
history of normal development followed by loss of 
acquired skills, including language, together with 
diarrhoea and abdominal pain….Onset of behavioural 
symptoms was associated, by the parents, with 
measles, mumps, and rubella vaccination in eight of 
the 12 children” [1].  
 This article flipped the concrete evidence-
based success story of vaccination into an emotionally 
charged and debatable topic of the century. It was only 
after a decade of much larger studies which failed to 
replicate their findings that it became evident that there 
was no association between Measles, Mumps and 
Rubella (MMR) vaccination and autism. While it is 
well known that scientific investigations can be wrong 
but what is unacceptable here is the fraudulent 
research practice, in this case, the presentation of 
wrong data, and the lead author’s overwhelming 
undeclared conflict of interest. The aftermath could not 
be more devastating, Lancet withdrew the paper fully 
and the loss of his license to practice medicine in the 
UK in 2010.  
 
THE WIDER IMPLICATION 
The MMR-Autism link saga to the medical world 
meant that more research, time and money were 
poured to refute the study and also to expose the fraud 
but the repercussions however were not only confined 
to the medical profession. The greatest damage was the 
appalling tangential increase in vaccine refusal among 
parents worldwide which fuelled the measles outbreak 
across the United Kingdom (UK), United States and 
Canada in the year 2008 and 2009. UK for example, 
saw a drop in vaccination rates from 87.4 percent to 
79.9 percent in the year 2000-01 and 2003-04 
respectively and not surprisingly, a dramatic increase 
in measles cases in the UK in the year 2007-08, which 
was equal to the combined total measles notifications 
for the past decade [2]. 
 As the news coverage on the controversy 
intensified, and coupled with advancement of 
technology in the social media network, the public 
perception on vaccination has suddenly changed, the 
most successful health revolution in the 20th century is 
now at stake. Seemingly increasing public distrust and 
confusion over the safety of vaccination were echoed 
and mischievously elaborated geographically, reaching 
out to most of the third world countries including 
Malaysia causing the dreaded domino effect of 
declining immunisation rates in many countries 
including our own. 
 
THE BLIGHT ON OUR SUCCESS 
We began our free national immunisation programme 
for Diphteria, Pertussis and Tetanus in 1958, the 
vaccination for Tuberculosis, Polio and Measles were 
gradually added into the immunization schedule 
between the years 1960 to 1980s. Malaysia has done 
very well since, based on the latest Millenium 
Development Goal (MDG) report in 2015, we have 
reached almost full coverage for one-year-old intake of 
the Measles, Mumps and Rubella (MMR) vaccine. The 
rate of intake of this vaccine was initially 70.1% in 
1990, with massive improvement to 94.3% (2008) and 
95.2% in 2013 [19], validated by a recent study in 
2016 from a rural clinic in Sabah at 98.5% [29]. 
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Lurking behind this success however is the rising trend 
of parents refusing to vaccinate their children. We now 
notice an increase in the number of vaccine refusal 
from 470 cases in 2013 to 648 in the following year 
and 1292 in 2015. Among the states in Malaysia, 
Kedah state recorded the highest number of vaccine 
rejection cases with steady rise from 239 cases in 2014 
to 318 cases a year later.  
 Why is this happening? Data from the state of 
Kedah health statistics suggested that the major cause 
for the refusal was the concern regarding the vaccine 
contents and their religious permissibility (halal). This 
is supported by a cross-sectional study in 2013 done in 
Perak that showed the main reasons for parental 
immunisation refusal were preference to alternative 
treatment (75%), assumption that vaccines have no 
effect (37.5%) and apprehension on the vaccine 
contents (25%), other reasons included not being 
informed regarding vaccination from health 
practitioners, information from family members and 
media, religious influence, personal belief and long 
waiting time in the clinic [18].  In this study the refusal 
rate was 8 per 10,000 children per year and 
immunisation defaulter rate was 30 in 10,000 children 
per year. Vaccine refusal could also be caused by 
deferral which could be due to either ill infants or 
parents missing the schedule or appointments [17].  
 The number of vaccine preventable diseases 
has also showed steady increment for the past few 
years, in tandem with the decrement of immunisation 
rates. Measles cases in Malaysia has quadrupled from 
195 cases in 2013 (6.6 cases per million population) to 
794 cases up till September 2016 (34.7 per million 
population). This is certainly a blight on our success 
and it pushes us off track from the MDG target of 
global measles elimination by 2015. 
 
APPREHENSION OF VACCINE CONTENT 
Certain chemicals are present as ingredients in the 
vaccines to ensure safety and effectiveness of the final 
products. These substances naturally exist in the 
environment and only become toxic if they reach or 
exceed a certain threshold. 
 Among chemicals used in vaccine preparation 
include thimerosal (mercury), which is an organic 
compound containing ethylmercury. Its primary role is 
to prevent bacterial and fungal contamination and has 
been used as vaccine preservative since 1930's [30]. 
 Virtually all vaccines are now mercury-free; 
and even if present its potential harmful effect is 
almost negligible as the chemical content in the 
vaccine is extremely low. 
 Aluminium is another compound used in 
vaccine preparation. It acts as an adjuvant to enhance 
the immune response to the vaccine antigen [30]. 
Exposure to aluminium from vaccines is well below 
the current minimum risk level of 2.0 mg/kg per day 
[30]. Interestingly, the content of aluminium is higher 
in breast milk compared to vaccines [31] as well in 
certain medications such as antacids [31]. 
 However, another reason of apprehension that 
is being used as bone of contention by anti-vaccination 
campaigners is the permissibility (halal) of the vaccine 
contents. 
 
THE ISLAMIC VIEWPOINT 
The objectives of Islamic law (maqasid shariah) are 
the preservation of five fundamental elements in a 
person; religion, life, lineage, intellect and property.  
Correspondingly, the maxim of Islamic law (Qawaid 
al Fiqh) adheres to the principle of avoiding harm, 
thus taking steps towards maintenance of health and 
this includes vaccine administrations to prevent serious 
and life-threatening illnesses among children are in 
accordance to these principles.  
 As stated earlier, the main religious 
consternation regarding vaccination among Muslims 
parents revolves around the issue of permissibility 
(halal) of the vaccine contents. In this regard, many 
scholars in Islamic Jurisprudence have in fact issued 
clear ruling (fatwa) regarding the permissibility of 
most vaccines used as part of national immunisation 
programmes worldwide, including Bacillus Calmette-
Guerin (BCG), Hepatitis B, Diphtheria, Tetanus, 
Pertussis and Rubella vaccines [20-24].  
 Differences of opinion however does exist 
among the scholars regarding vaccines that have 
substances derived from pork, which are forbidden 
(haram) in Islam, being used during their 
manufacturing process. As an example, for the 
production of oral polio and rotavirus vaccines, trypsin 
enzyme of porcine origin is used during production to 
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dissociate the virus from cultured cells, but it is later 
removed through the process of microfiltration.  The 
use of this substance however has led the Malaysian 
Fatwa Committee National Council of Islamic 
Religious Affairs in 2008 to issue a ruling that the use 
of Rotavirus vaccine is forbidden, other religious 
considerations by the council include the availability 
of an alternative trypsin source and the absence of an 
urgent state (darurah) for its use. But other opinion 
does exist which can be considered to be more in tune 
with the spirit of Islam that discourages complexity in 
performance of religious duties, the ruling from the 
European Council of Fatwa & Research in 2003 led by 
Yusuf al-Qardhawi. He concluded that the use of oral 
polio vaccine was permissible based on the following 
reasons; the negligible amount of trypsin used in the 
vaccine preparation, the fact that trypsin is filtered and 
thus not detectable in the final vaccine, and finally 
what is forbidden (haram) is made permissible in the 
state of necessity. As a result of this ruling, many 
Muslim countries such as Saudi Arabia, Bahrain, 
Yemen, Qatar, Iraq, Morocco, Sudan and Pakistan [20] 
have incorporated Rotavirus vaccine that uses porcine 
trypsin in their national immunisation programmes. 
 
THE WAY FORWARD 
This requires efforts by all relevant stakeholders, 
government and non-government, to reverse the trend 
we see locally as well as worldwide. One great stride 
forward was the WHO approved Global Vaccine 
Action Plan, a framework to prevent millions of deaths 
by 2020 through more equitable access to existing 
vaccines for all peoples in all communities [30]. The 
aims here are to strengthen routine immunisation to 
meet vaccination coverage target, accelerate control of 
vaccine-preventable diseases as well spur research for 
development of new and improved vaccines [30]. 
 Healthcare providers are undoubtedly the front 
liners in educating the parents and clarifying any 
doubts which may prohibit vaccine adherence among 
them.  We know that counseling parents with clear 
information about the risks and benefits of vaccines, 
and taking advantage of clinical consultation visits for 
explanation of immunisation are among the most 
effective strategies suggested to achieve this [31]. In 
Malaysia, forums and educational talks to the general 
public are actively organised by the Malaysian 
Ministry of Health and other non-governmental 
organisations to reach for these parents at all levels and 
localities. Besides that, social media is also very 
effective and is a borderless educational platform to 
reach the community.   
 Finally, the history of vaccination had been a 
great success story of the last century, Measles 
vaccination alone has been estimated to have helped 
save 17.1 million lives in the year 2000 [27]. Lack of 
knowledge on the issue compounded with 
contradictory information in social media have led to 
the disruption of herd immunity that previously had 
been the gate keeper in protecting our children from 
vaccine-preventable disease. We must do all we can to 
ensure it remains a success. 
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THE TRADITIONAL CURRICULUM 
Medical education in Malaysia has evolved in the past 
50 years since independence. This paper highlights the 
various stages of curriculum development that were 
made to meet the needs of the developing country. 
 Malaya was under British rule between the 
18th and the 20th Centuries. British Malaya as it was 
then known comprised of the Peninsular States and the 
Straits Settlements of Penang, Malacca and Singapore.  
Western medicine was introduced to the then Malaya 
in Singapore, with the setting up of the first medical 
school in 1907. It was called the Government Medical 
School and later became known as the King George 
VII College of Medicine in Singapore. In 1910 the first 
batch of seven male Medical graduates received their 
Licentiate in Medicine and Surgery (LMS) [1]. 
 In 1949, the University of Malaya was 
established, based in Singapore, with a branch set up in 
Kuala Lumpur in 1959.  In 1961, both governments of 
Singapore and Malaya agreed and passed legislation in 
Parliament to make the Kuala Lumpur Campus an 
autonomous body known as the University of Malaya; 
with its own medical school and teaching hospital.  
Thus in 1962, the government approved the setting up 
of  the University of Malaya Medical Faculty, together 
with its teaching hospital, in the Klang Valley. The 
Faculty became fully functional in 1964 with the first 
intake of 64 medical students. After the hospital was 
built, the whole complex was named the “University of 
Malaya Medical Centre (UMMC)”, with facilities for 
undergraduate medical teaching, hospital services, the 
nursing school and other ancillary services put in place 
[2].  
 Professor Thumboo John Danaraj who was 
then Professor of Medicine in the Medical Faculty at 
the University of Singapore, was appointed as 
Founding Dean of the Medical Faculty, University of 
Malaya in Kuala Lumpur [3].   With his appointment, 
the process of “head hunting” and appointment of 
academic staff began together with the selection of 
potential students for the first academic session.  
 It was mandatory that the Faculty get relevant 
and competent professionals to start the ball rolling.  
These medical academicians came from different parts 
of the globe, including Sri Lanka, Canada, Singapore 
and the UK (Figure 1). 
 
 
Figure 1 The founding teachers: Faculty of Medicine, University of 
Malaya, 1965 (Courtesy of the late Prof. TJ Danaraj). 
 
 
With these academicians on board, the toiling 
of planning and designing of the medical curriculum 
started since the first batch of medical students was 
scheduled to enter the medical school in 1964. 
 Globally, the medical curriculum followed the 
traditional didactic teaching of basic sciences 
comprising of anatomy, physiology and biochemistry 
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in the first year of undergraduate medical course. In 
the second year, the subjects of pathology, 
pharmacology, medical microbiology and parasitology 
were introduced. This was interspersed with topics on 
communicable diseases and principles of social and 
preventive medicine (SPM).  The thrust of the 
undergraduate curriculum then was in the various 
aspects of issues related to social and preventive 
medicine.  This was deemed to be important because 
the newly formed Malaysia, for the most part, was still 
mostly rural. 
 Professor Danaraj, having had experience as 
an academician in Singapore, felt that the didactic 
teaching of “dry” basic science subjects may not be 
perceived as interesting and relevant by the medical 
students.  Thus, early on in the undergraduate medical 
curriculum, he introduced the clinical correlation 
classes (CCC) with clinical cases brought to the 
auditorium to demonstrate the physical signs and 
correlate them with basic science topics that were 
learnt during the previous week (Figure 2).  This made 
the preclinical students understand the importance of 
basic medical science subjects in order to be able to 
explain the symptoms and the development of physical 
signs when disease occurs. 
 
 
Figure 2 Clinical Auditorium, University of Malaya Medical Faculty. 
Clinical integration with patients starts in year 1 (CCC) (1967) [Courtesy of 
the late Prof. TJ Danaraj]. 
 
 
This was perhaps the earliest change in the 
curriculum to facilitate the teachers to think about 
possibilities of making basic science “dry topics” more 
interesting to the students. This gradual introduction of 
clinical medicine into basic science “preclinical years” 
and vice versa in the clinical years was perhaps the 
beginning of integrated teaching and the evolution of 
the undergraduate medical curriculum in Malaysia in 
the late 1980’s.   
 The clinical years begin from years 3 to 5 with 
rotations in general medicine, surgery, paediatrics 
orthopedics and obstetrics and gynaecology. In the 
clinical years, the integration of basic sciences in the 
form of clinico-pathological case (CPCs) discussions 
in the final year, sets the stage for future developments 
in the undergraduate curriculum. The clinical postings 
and the CPCs were meant to expose the students to 
develop their critical and analytical thinking skills 
during their clinical clerkships. Thus, learning to make 
reasonable diagnoses based on patho-physiological 
processes that had occurred, with minimal 
investigative procedures. This was meant to prepare 
them for their general medical service as medical 
officers in the rural areas, and also providing them 
with the basics for future career development. 
 
NATIONAL STRATEGIES TO IMPROVE 
HEALTH CARE FOR THE POPULATION 
Let us now look at the needs of the country then, and 
how the medical schools were tasked by the 
Government to contribute towards improving the 
health services in the then rural Malaysian society. 
 During the British Administration of the then 
Malaya, the legacy left behind by the British was a 
network of health services that extended to the really 
remote parts of Peninsular Malaya [4], as depicted in 
Figure 3. 
  When Malaya had her independence in 1957, 
the health programs were somewhat coordinated 
although there was a gross deficiency of doctors to run 
the district hospitals and the general hospitals. 
Healthcare then was provided at best by the hospital 
assistants (now known as medical assistants, MA).
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Figure 3 Network of Government run Health Care Services (Legacy from the British Rule of Malaya). a) Rural health unit. b) Replica of the original photo 
(Courtesy of the late Prof. TJ Danaraj). 
 
During this period the teaching of medicine 
closely followed the British medical education system 
that was practiced in the UK.  In those early days, the 
teaching of medicine was by apprenticeship with some 
knowledge of basic sciences to explain the symptoms.  
 Then came the didactic (traditional); and 
scientific discipline model. This preceptor-ship had 
advantages especially when there was as yet no formal 
structured curriculum mapping. To this day, clinical 
mentoring and preceptor-ship is practiced to some 
extent in the clinical ward rounds with bedside 
teaching.  The concept of mentoring and development 
of clinical acumen was very apt in clinical practice; 
both during the undergraduate days and continues in 
the world of medical academia to this day.  This is an 
art that is slowly dying with the advent of investigative 
medical practices.  
 While doctors have to know how to use 
modern investigative tools, clinical acumen is still 
required, to be able to make reasonable diagnosis and 
institute treatment; to be able to determine what 
investigations are appropriate and when referrals are 
necessary. This is so because government-sponsored 
medical graduates face compulsory service that may be 
in rural areas where there is scarce   advanced 
investigative tools to aid them in making the diagnosis.  
 In the 1990’s with the inevitable trend of 
producing more specialists, it was deemed necessary 
for the Ministry of Health to ensure that there will be 
enough primary care providers and general physicians 
who would approach patients in a holistic manner.  
This was tasked to the universities to take the lead to 
develop programs to train medical officers as 
generalists and family and primary care physicians.   
 Medical schools in Malaysia, in developing 
their medical curriculum, need to address these issues 
and tailor-make the curriculum to suit the healthcare 
needs of the country. 
 
To be continued in Part 2: The Blended 
Curriculum  
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INTRODUCTION 
Streptococcus pneumoniae is an important bacterial 
pathogen and is a major causative agent of respiratory 
infections. It also causes otitis media, pneumonia, 
sinusitis, meningitis, and septicemia and is frequently 
associated with significant morbidity and mortality [1]. 
 During the early 1940’s, isolates of S. 
pneumoniae were highly susceptible to penicillin, 
which was the drug of choice for suspected 
pneumococcal infections [2]. However, in the 1970’s, 
penicillin-resistant and multidrug resistant 
pneumococcus was first reported in South Africa [3].  
Since then, the rate of antibiotic resistance among 
pneumococci isolates to various antimicrobial agents 
has increased. S. pneumoniae resistance to penicillin is 
due to the alteration of the penicillin binding proteins 
(pbp1A, pbp2B, pbp2X), which reduces its binding 
affinity to -lactams.  Hence, cross resistance to other 
-lactam drugs such as cephalosporins is not 
uncommon.  -lactam resistance in S. pneumoniae has 
brought a need for alternative antibiotics such as 
macrolides and fluoroquinolones.  These are frequently 
used as empirical therapy in respiratory tract infection, 
which has resulted in increased prevalence of macrolide 
resistant strains of S. pneumoniae. 
 Macrolide resistance in S. pneumoniae is a 
result of modification of the ribosomal target site 
adenine at position 2058 [4], as the A2058 nucleotide 
has a key function in the binding of this antibiotic. This 
modification results in a reduction of macrolide binding 
affinity to its target or modification of the conformation 
of binding site. This mechanism of resistance is 
assigned by the determinant gene, ermB. Macrolides 
resistance is also caused by another mechanism, which 
is the efflux mechanism of the drug and assigned as 
mefE. 
 Recently, strains of S. pneumoniae have 
developed resistance to fluoroquinolones, which have a 
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greater intrinsic activity against this organism. Previous 
studies have shown that the fluoroquinolones target the 
type II topoisomerase, DNA gyrase and topoisomerase 
IV [5, 6]. Amino acid substitution within the Quinolone 
Resistance Determining Region (QRDR) of these 
enzymes has resulted in resistance to fluoroquinolones 
in S. pneumoniae [6, 7]. 
 The increase in incidence of multi-drug 
resistance among S. pneumoniae necessitates a need for 
a tool to identify the presence of these genes within the 
strains in order to institute appropriate antimicrobial 
therapy.  In this study, we have used 2 sets of multiplex 
PCRs (quintuplex and triplex PCR)  assay to identify 
and characterize the antibiotic resistance genes, ermB, 
pbp1A, gyrA, mefE simultaneously with the S. 
pneumoniae species specific pneumolysin gene and the 
common eubacteria gene. 
 
METHODS 
Bacterial Strains 
One hundred and twenty pneumococcal isolates were 
obtained from clinical samples processed at the 
Microbiology Laboratory of the University Malaya 
Medical Centre, Malaysia from March 1999 to 
December 2003.  The isolates were obtained from both 
pediatric and adult patients.  The source of the isolates 
included blood, nasopharyngeal secretion, tracheal 
secretion, sputum and bronchoalveolar lavage.  Samples 
were grown on 5 % horse blood agar and incubated at 
37o C in 5 % CO2 for 12 -15 hours prior to other 
biochemical and molecular assays. 
 
Strain Identification 
The strains were identified as S. pneumoniae using 
conventional microbiological methods including 
susceptibility to ethylhydrocupreine disc (optochin), 
catalase test and bile solubility. 
 
Susceptibility Testing 
The antibiotic susceptibility of the strains was tested on 
Mueller Hinton Agar (Oxoid) plates containing 5 % 
sheep blood (Oxoid), incubated at 37o C with 5 % CO2 
using the agar dilution method as described [8]. The 
antimicrobial agents used were penicillin, cefotaxime, 
ceftriaxone, and erythromycin.  The antibiotics were 
obtained from Sigma Aldrich (Sigma Chemical Co., St. 
Louis, Mo). S. pneumoniae ATCC 49619 was used as 
control. Strains were also tested against ciprofloxacin 
(Bayer, Germany), moxifloxacin (Bayer, Germany), 
gatifloxacin (Bristol-Myers Squibb, New Jersey, USA) 
and levofloxacin (Daiichi, Japan). 
 
DNA Extraction 
Genomic DNA was extracted from the bacterial culture 
using a previously described method [9].  Bacterial 
colonies suspended in 15 l of dH2O containing 
50g/mL were incubated at 37o C for 10 minutes. This 
was followed by addition of 10g/mL Proteinase K and 
0.1mM Tris HCL pH 7.5 and incubated at 37o C for 
another 10 minutes. Subsequently, the suspension was 
boiled for 5 minutes and finally centrifuged at 13000 
rpm for 2 minutes.  The supernatant obtained was used 
as the template in the PCR reaction. The extraction of 
DNA from blood samples was carried out using the 
standard phenol-chloroform extraction protocol [10].  
 
PCR Amplification 
The primers used in this study were extracted from 
previously published sequences [11].  The optimal PCR 
condition for a 50 l reaction included 1X PCR buffer, 
1.5mM MgCl2, 0.2 mM dNTP mix, 2U Taq Polymerase 
(Fermentas) and 20 pmol of each primer. The PCR 
cycling parameters were as follows: An initial 
denaturation step at 94o C for 5 minutes, 15 cycles of 
amplification performed as follows: denaturation at 94o 
C for 30s, annealing temperature at 40o C for 30s and 
extension temperature at 72o C for 30s. Thereafter, 
another 20 cycles of amplification were completed as 
above but with an annealing temperature of 46o C and 
finally completed with an extension at 72o C for 2 
minutes. The amplification reaction was performed in 
an Eppendorf Gradient Mastercycler. The PCR product 
was electrophoresed on a 2 % TAE agarose gel for 1 
hour at 70V and the bands were analyzed using a UV 
trans illuminator.  
 
Determination of Sensitivity and Specificity of 
the Assay 
The sensitivity of the assay was determined using pure 
bacterial cultures and spiked blood samples.  Colonies 
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from overnight grown pure bacterial cultures were 
suspended in 0.85 % NaCl and the turbidity adjusted to 
an OD equivalent to 0.5 McFarland standards, which is 
approximately 108 cfu / ml. Further 10 fold dilutions of 
the suspension were made up to 10 cfu / ml. DNA 
extraction was carried out on each dilution, which was 
later subjected to PCR amplification.  The sensitivity of 
the assay in the clinical setting was carried out by 
simulating known concentration of bacterial cultures 
and human blood samples into blood culture bottles.  
This was carried out by inoculating 5 mL of healthy 
volunteer blood into an aerobic blood culture media 
(BD Biosciences, Becton Dickinson, USA), and the 
bottle was spiked with 100 L of diluted culture 
suspension, which ranged from 108  to 103 cfu. The final 
concentration of the bacteria in the blood culture bottles 
ranged from 106 to 10 cfu, considering 25 mL of the 
culture media (25 mL) in the blood culture bottles. The 
blood culture bottle was incubated overnight at 37o C, 
prior to DNA extraction and PCR amplification. Viable 
bacterial count in the blood culture media was 
determined before and after the incubation period. The 
DNA from blood cultures was extracted using the 
method previously described [10]. The DNA extracted 
from each blood culture bottle with known 
concentration of bacterial culture was subjected to PCR. 
The specificity of the assay was also evaluated using 
DNA extracted from other gram positive bacteria such 
as Streptococcus sanguis ATCC 10556, Staphylococcus 
aureus ATCC 25923 as well as gram negative bacteria 
including Acinetobacter baumannii ATCC 15308 and 
Pseudomonas sp. 
 
RESULTS 
The pneumococcal strains were assigned into 3 groups 
based on their susceptibility levels to penicillin i.e. 
penicillin sensitive S. pneumoniae (PSSP) for strains 
with penicillin MIC of < 0.125 µg/mL, penicillin 
intermediate S. pneumoniae (PISP) for strains with 
penicillin MIC of ≥ 0.125 - < 1.0 µg/mL and penicillin 
resistant S. pneumoniae (PRSP) for strains with 
penicillin MIC of > 1.0 µg / mL. There were 58 PSSP 
strains, 36 PISP strains and 26 PRSP strains. Out of the 
120 pneumococcal isolates that were tested, 64 strains 
were sensitive to erythromycin, 12 intermediate to and 
44 resistant to erythromycin. 
 MIC of representative strains used in this study 
is shown in Table 1. All 120 isolates were characterized 
using PCR.  In Table 1, strains I18, R55, R88 and R100 
are representative of PRSP strains, while strains R71, 
R81, R77, R72 and I99 represent the PISP strains. The 
control strains used in the study were S. pneumoniae 
ATCC 700676 and S. pneumoniae ATCC 49619 
representing the PSSP and PISP strains respectively. 
 
Table 1 MICs of the representative strains used in the study 
STRAINS 
MIC ( g/ml )* 
PEN CRO CTX ERY 
ATCC 
700676 
0.032 (S) 0.064 (S) < 0.032 (S) 2.0 (R) 
ATCC 
49619 
0.5 (I) 0.064 (S) 0.125 (S) 0.125 (S) 
(I18) 2.0 (R) 1.0 (I) 2.0 (R) 128.0 (R) 
(R71) 1.0 (I) 1.0 (I) 0.5 (S) 0.5 (I) 
(R81) 1.0 (I) 1.0 (I) 1.0 (I) 2.0 (R) 
(R77) 1.0 (I) 1.0 (I) 0.5 (S) 2.0 (R) 
(R55) 2.0 (R) 2.0 (R) 2.0 (R) 1.0 (I) 
(R88) 2.0 (R) 1.0 (I) < 0.032 (S) 1.0 (I) 
(R72) 1.0 (I) 1.0 (I) 0.5 (S) > 1.0 (S) 
(I99) 0.125 (I) 0.25 (S) 1.0 (I) 0.016 (S) 
(R100) 2.0 (R) 1.0 (I) 1.0 (I) 2.0 (R) 
(Direct 
Blood 
Culture) 
S S Not tested S 
PEN (S: ≤ 0.06, I: 0.12 – 1.0, R: ≥ 2.0), CRO (S: ≤ 0.5, I: 1.0, R: ≥ 2.0), CTX 
(S: ≤ 0.5, I: 1.0, R: ≥ 2.0), ERY (S: ≤ 0.25, I: 0.5, R: ≥ 2.0)  
 
 
 Figure 1 illustrates the quintuplex PCR 
amplification assay on representative strains. The 
pneumolysin (ply) gene, which encodes the S. 
pneumoniae species specific gene, was amplified in all 
the S. pneumoniae strains and the common eubacterial 
gene, which acts as an internal control was also detected 
in all the strains. The pbp1A gene was not amplified in 
strains I18, R71, R81, R77, R55 and R100 but had 
positive amplification in strains R88, R72 and I99. The 
ermB gene was only detected in strains I18, R71 R77, 
R88, and I99.  The eubacterial gene was amplified in all 
the strains.  This confirms the presence of bacterial 
DNA. The pneumolysin gene (ply) was also amplified 
in all the S. pneumoniae strains which serve as S. 
pneumoniae species specific gene.  Amplification of the 
gyrA gene in all the strains does not imply antibiotic 
resistance but acts as a housekeeping gene in this 
organism. 
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Figure 1 Screening of isolate using quintuplex PCR 
 
Lane 1: Negative control 
Lane 2: Strain I18 
Lane 3: Strain R71 
Lane 4: Strain R81 
Lane 5: Strain R77 
Lane 6: Strain R55 
Lane 7: Strain R88 
Lane 8: Strain R72 
Lane 9: Strain I99 
Lane 10: Strain R100 
Lane 11: 100 bp DNA ladder 
Lane 12: Direct blood culture isolate 
 
 
The specificity of the quintuplex PCR was also 
tested against other gram negative and gram positive 
bacteria as shown in Figure 2. The S. pneumoniae 
species specific gene, pneumolysin (ply), was only 
detected in the S. pneumoniae strain R81 whereas this 
gene was not amplified in the other gram positive 
(Streptococcus sanguis ATCC 10556, Staphylococcus 
aureus ATCC 25923) and gram negative bacteria 
(Acinetobacter baumannii ATCC 15308, Pseudomonas 
sp.) that were tested. The gene encoding the common 
region of the eubacteria was detected in all the bacterial 
isolates tested.  Similarly, the common eubacterial gene 
was also observed in the blood culture bottles that were 
spiked with known amount of bacterial suspension. 
 
 
Figure 2 PCR amplification to test the specificity of the assay 
 
Lane 1: Negative control 
Lane 2: Acinetobacter sp. 
Lane 3: Pseudomonas sp. 
Lane 4: Streptococcus sanguis 
Lane 5: Staphylococcus aureus and) were tested. 
Lane 6: Lane Streptococcus pneumoniae 
Lane 7: 100bp DNA ladder 
 
The lower limit of detection of the assay was 
determined to be as low as 10 CFU as illustrated in 
Figure 3. This was evident as the genes were not clearly 
observed in blood culture bottles spiked with lowest 
concentration of bacteria (Figure 3).  
 
Figure 3 Amplification of the quintuplex PCR assay of simulated blood 
culture with known concentration of template to test the sensitivity of the 
assay 
 
Lane 1: Negative control 
Lane 2: Concentration of 106 cfu 
Lane 3: Concentration of 105 cfu 
Lane 4: Concentration of 104 cfu 
Lane 5: Concentration of 103 cfu 
Lane 6: Concentration of 102 cfu 
Lane 7: Concentration of 10 cfu 
Lane 8: 100 bp DNA ladder 
 
 
The triplex PCR was used in addition to the 
quintuplex PCR to characterize the macrolide resistant 
strains, which did not harbour the ermB gene. Using the 
triplex PCR, only 33 of the 44 erythromycin resistant 
strains harboured the ermB gene, while 5 of 12 
erythromycin intermediate strains harboured the ermB 
gene. Strains that were negative for the ermB gene were 
further tested for the presence of the mefE gene. Results 
obtained showed that the strains negative for ermB 
harboured the mefE gene instead. Figure 4 illustrates the 
PCR amplification of representative strains using the 
triplex PCR assay for the detection of ermB and mefE 
simultaneously.  
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Figure 4 Triplex PCR of the macrolide resistance determinants and 
S.pneumoniae specific gene 
 
Lane 1: 100 bp DNA ladder 
Lane 2: Strain I20 
Lane 3: Strain I28 
Lane 4: Strain R76 
Lane 5: Strain R17 
Lane 6: Strain R46 
Lane 7: Negative control 
 
 
DISCUSSION 
-lactam antibiotics inhibit the growth of S. 
pneumoniae by inactivating the penicillin-binding 
proteins (PBPs), which are essential in cell wall 
synthesis. Resistance to -lactams is due to alterations 
in the PBPs, resulting in reduced affinity of binding of 
the drug.  In this study, the amplification of pbp1A gene 
is an indication of non-altered PBPs whereas no 
amplification of the pbp1A gene indicates alteration in 
the gene. Previous studies have shown that alteration in 
PBPs 2B, 2X and 1A confers penicillin resistance [12] 
but only alterations in pbp2X and 1A confers 
cefotaxime resistance [13].  However, alteration in 
pbp1A is essential to confer high-level resistance [14, 
15, 16], hence the identification of pbp1A could be 
useful for detecting high-level penicillin resistance. 
 In this study, the pbp1A gene was detected by 
the quintuplex PCR in the 58 strains that were sensitive 
to penicillin but was not detected in all the 36 strains 
and 26 strains that were intermediate and resistant 
respectively to penicillin. The negative amplification of 
pbp1A gene indicates an alteration within the pbp1A, 
whereas presence of the gene indicates a susceptible 
strain with no alteration. An alteration in the penicillin 
binding proteins reduces its affinity of binding to -
lactams, hence reducing the susceptibility of the 
antibiotic to the organism.  In our findings, 
amplification of the pbp1A gene in strains R88, R72 and 
I99 indicates that there was no alteration in this gene. 
However, there could be alteration in the other PBPs 
that may have caused these strains to develop resistance 
to penicillin. 
 Using the quintuplex PCR, the ermB gene was 
detected in 38 strains, of which, 5 were intermediate and 
33 were resistant to erythromycin. Some strains that 
harboured the ermB gene had also possessed the mefE 
gene (triplex PCR), which confers resistance to 
macrolides via the efflux mechanism and some of the 
strains that were negative for the presence the ermB 
gene, showed positive amplification of the mefE gene 
instead. 
 An attempt to incorporate the mefE gene into 
the quintuplex PCR was unsuccessful as it was 
inhibiting the detection of the other genes 
simultaneously. Macrolide resistance is conferred by 
the presence of the ermB or mefE or both the genes. The 
ermB was incorporated into the multiplex because of its 
high prevalence. The ermB determinant is borne by 
conjugative transposons related to Tn1545, Tn1545-like 
elements or a Tn 917-like element, that is part of a larger 
composite transposon, Tn 3872 [17,18].  This accounts 
for horizontal transfer of the element and results in a 
higher prevalence of the ermB determinant.  
 The detection of the gyrA gene by PCR in both 
fluoroquinolones susceptible and non-susceptible 
strains indicates no significance in the presence of the 
gene, with regards to the development of 
fluoroquinolones resistance.  However, this gene acts as 
a housekeeping gene in S. pneumoniae.  
Fluoroquinolones resistance in S. pneumoniae is 
conferred by point mutations within the Quinolone 
Resistance Determining Region (QRDR).  The targets 
of fluoroquinolones are the type II and type IV 
topoisomerases encoded by the gyrA, gyrB, parC and 
parE genes. Therefore, point mutations conferring 
fluoroquinolone resistance may occur in either one or 
more of these genes. In order to detect these mutations, 
PCR DNA sequencing needs to be carried out on all the 
strains.  
 Isolates from direct blood cultures that were 
confirmed gram positive by gram staining were also 
characterized using the two multiplex PCRs.  In this 
study, Streptococcus group B and Viridans group 
Streptococci were used. The assay showed promising 
Quintuplex PCR for S. pneumoniae 
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results as only the internal control gene was amplified 
by the assay.  This shows that the assay is 100 % genus 
and species specific. The lower limit of detection of the 
quintuplex PCR of up to 10 CFU/mL would allow 
characterization of S. pneumoniae strains from cultures 
containing low levels of bacterial load of infection.  
 The characterization of S. pneumoniae strains 
using multiplex PCR has an advantage with a shorter 
turnaround time. Detection of S. pneumoniae and its 
antibiotic resistance genes from a bacterial culture is 
possible within 3-4 hours using the multiplex PCR 
assays. The identification of the antibiotic resistance 
genes allows prediction of the appropriate drug therapy. 
Several investigators have evaluated PCR as a tool for 
diagnosis of pneumococcal infection [10, 19, 20].  
However, previous researchers focused solely on 
identifying pneumococcal infections from infants and 
children.  Most studies concentrated on detecting the 
pneumolysin gene in different sources of samples, such 
as sputum, urine and blood.  In this study, we used the 
multiplex PCR assay to characterize the strains and 
identify genes encoding antibiotic resistance, which are 
commonly prescribed; penicillin and macrolides. Other 
researchers have also detected antibiotic resistance 
genes via PCR, whereby, PCR has been used to detect 
different classes of antibiotics separately in different 
tubes as compared to the multiplex PCR assay, which 
detects 3 different classes of antibiotics in one tube and 
also specifically detects S. pneumoniae via the detection 
of the S. pneumoniae species specific genes, 
pneumolysin (ply).  Therefore, we conclude that 
characterization of S. pneumoniae strains could be 
carried out using multiplex PCR in order to shorten the 
turnaround time, hence avoiding unnecessary drug 
prescription. 
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